25 XP   0   0   10

Fortress Biotech Inc
Buy, Hold or Sell?

Let's analyze Fortress Biotech Inc together

I guess you are interested in Fortress Biotech Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Fortress Biotech Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Fortress Biotech Inc

I send you an email if I find something interesting about Fortress Biotech Inc.

Quick analysis of Fortress Biotech Inc (30 sec.)










What can you expect buying and holding a share of Fortress Biotech Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.44
When do you have the money?
1 year
How often do you get paid?
67.5%

What is your share worth?

Current worth
$-0.20
Expected worth in 1 year
$-1.39
How sure are you?
42.5%

+ What do you gain per year?

Total Gains per Share
$-0.75
Return On Investment
-42.8%

For what price can you sell your share?

Current Price per Share
$1.76
Expected price per share
$1.66 - $1.76
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Fortress Biotech Inc (5 min.)




Live pricePrice per Share (EOD)

$1.76

Intrinsic Value Per Share

$-69.95 - $-50.85

Total Value Per Share

$-70.15 - $-51.05

2. Growth of Fortress Biotech Inc (5 min.)




Is Fortress Biotech Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$3.9m$79.7m-$87.6m-1,111.2%

How much money is Fortress Biotech Inc making?

Current yearPrevious yearGrowGrow %
Making money-$14.2m-$28.4m$14.2m100.4%
Net Profit Margin-84.9%-180.8%--

How much money comes from the company's main activities?

3. Financial Health of Fortress Biotech Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#864 / 966

Most Revenue
#204 / 966

Most Profit
#626 / 966

Most Efficient
#456 / 966
3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Fortress Biotech Inc? (5 min.)

Welcome investor! Fortress Biotech Inc's management wants to use your money to grow the business. In return you get a share of Fortress Biotech Inc.

What can you expect buying and holding a share of Fortress Biotech Inc?

First you should know what it really means to hold a share of Fortress Biotech Inc. And how you can make/lose money.

Speculation

The Price per Share of Fortress Biotech Inc is $1.76. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Fortress Biotech Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Fortress Biotech Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.20. Based on the TTM, the Book Value Change Per Share is $-0.30 per quarter. Based on the YOY, the Book Value Change Per Share is $-2.18 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.11 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Fortress Biotech Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.89-50.6%-0.74-42.0%-0.96-54.6%-0.76-43.3%-0.79-45.1%
Usd Book Value Change Per Share-0.28-15.8%-0.30-16.9%-2.18-123.9%-0.14-7.8%-0.10-5.7%
Usd Dividend Per Share0.116.2%0.116.2%0.116.3%0.095.2%0.052.8%
Usd Total Gains Per Share-0.17-9.5%-0.19-10.7%-2.07-117.7%-0.05-2.6%-0.05-2.8%
Usd Price Per Share2.00-1.46-0.41-0.53-0.41-
Price to Earnings Ratio-0.56--0.64--0.10--0.23--0.14-
Price-to-Total Gains Ratio-11.93--1.89--0.23--0.44--1.14-
Price to Book Ratio-10.12-6.63-0.28-1.40-0.74-
Price-to-Total Gains Ratio-11.93--1.89--0.23--0.44--1.14-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.76
Number of shares568
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.110.09
Usd Book Value Change Per Share-0.30-0.14
Usd Total Gains Per Share-0.19-0.05
Gains per Quarter (568 shares)-106.84-25.89
Gains per Year (568 shares)-427.37-103.57
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1250-677-437208-312-114
2500-1354-864416-623-218
3749-2031-1291624-935-322
4999-2709-1718832-1247-426
51249-3386-21451041-1558-530
61499-4063-25721249-1870-634
71748-4740-29991457-2182-738
81998-5417-34261665-2494-842
92248-6094-38531873-2805-946
102498-6771-42802081-3117-1050

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%3.037.00.07.5%3.051.01.05.5%
Book Value Change Per Share2.02.00.050.0%4.08.00.033.3%10.010.00.050.0%17.023.00.042.5%23.030.02.041.8%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%27.00.013.067.5%30.00.025.054.5%
Total Gains per Share2.02.00.050.0%4.08.00.033.3%10.010.00.050.0%17.023.00.042.5%24.029.02.043.6%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Fortress Biotech Inc

About Fortress Biotech Inc

Fortress Biotech, Inc., a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet. It also develops late stage product candidates, such as intravenous Tramadol for the treatment of post-operative acute pain; CUTX-101, an injection for the treatment of Menkes disease; Cosibelimab for metastatic cancers; Olafertinib for the treatment of patients with EGFR mutation-positive NSCLC; CAEL-101 for the treatment of amyloid light chain amyloidosis; Triplex vaccine for cytomegalovirus; and DFD-29 for the treatment of rosacea. The company's early stage product candidates include Dotinurad for gout; MB-106 for B-cell non-hodgkin lymphoma; MB-101 for glioblastoma; MB-108 for recurrent GBM; MB-109 for refractory glioblastoma; AJ201, an androgen receptor degradation enhancer; BAER-101, a positive allosteric modulator; MB-117 for newly diagnosed x-linked severe combined immunodeficiency; and MB217 for previously transplanted; and MB-110 for RAG1 severe combined immunodeficiency. Its preclinical product candidates comprise Mayo Clinic In Vivo CAR T Platform Technology; AAV-ATP7A gene therapy; AVTS-001 gene therapy; CK-103 BET inhibitor; CEVA-D and CEVA-102; CK-302, an anti-GITR; CK-303, an anti-CAIX; and oligonucleotide platform. The company was formerly known as Coronado Biosciences, Inc. and changed its name to Fortress Biotech, Inc. in April 2015. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Islands, Florida.

Fundamental data was last updated by Penke on 2024-06-17 20:52:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Fortress Biotech Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Fortress Biotech Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Fortress Biotech Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -136.1% means that $-1.36 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Fortress Biotech Inc:

  • The MRQ is -136.1%. The company is making a huge loss. -2
  • The TTM is -84.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-136.1%TTM-84.9%-51.2%
TTM-84.9%YOY-180.8%+95.9%
TTM-84.9%5Y-116.1%+31.2%
5Y-116.1%10Y-2,156.3%+2,040.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-136.1%-168.0%+31.9%
TTM-84.9%-209.9%+125.0%
YOY-180.8%-242.3%+61.5%
5Y-116.1%-401.7%+285.6%
10Y-2,156.3%-532.2%-1,624.1%
1.1.2. Return on Assets

Shows how efficient Fortress Biotech Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Fortress Biotech Inc to the Biotechnology industry mean.
  • -10.8% Return on Assets means that Fortress Biotech Inc generated $-0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Fortress Biotech Inc:

  • The MRQ is -10.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.8%TTM-8.3%-2.4%
TTM-8.3%YOY-9.5%+1.1%
TTM-8.3%5Y-6.3%-2.1%
5Y-6.3%10Y-7.6%+1.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.8%-11.9%+1.1%
TTM-8.3%-11.9%+3.6%
YOY-9.5%-11.3%+1.8%
5Y-6.3%-13.5%+7.2%
10Y-7.6%-14.9%+7.3%
1.1.3. Return on Equity

Shows how efficient Fortress Biotech Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Fortress Biotech Inc to the Biotechnology industry mean.
  • -77.0% Return on Equity means Fortress Biotech Inc generated $-0.77 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Fortress Biotech Inc:

  • The MRQ is -77.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -70.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-77.0%TTM-70.6%-6.4%
TTM-70.6%YOY-61.6%-9.0%
TTM-70.6%5Y-41.4%-29.2%
5Y-41.4%10Y-67.5%+26.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-77.0%-14.2%-62.8%
TTM-70.6%-15.7%-54.9%
YOY-61.6%-14.3%-47.3%
5Y-41.4%-19.2%-22.2%
10Y-67.5%-19.7%-47.8%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Fortress Biotech Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Fortress Biotech Inc is operating .

  • Measures how much profit Fortress Biotech Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Fortress Biotech Inc to the Biotechnology industry mean.
  • An Operating Margin of -293.8% means the company generated $-2.94  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Fortress Biotech Inc:

  • The MRQ is -293.8%. The company is operating very inefficient. -2
  • The TTM is -175.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-293.8%TTM-175.3%-118.5%
TTM-175.3%YOY-343.1%+167.8%
TTM-175.3%5Y-248.2%+72.9%
5Y-248.2%10Y-2,260.2%+2,012.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-293.8%-354.6%+60.8%
TTM-175.3%-225.9%+50.6%
YOY-343.1%-252.2%-90.9%
5Y-248.2%-428.3%+180.1%
10Y-2,260.2%-531.1%-1,729.1%
1.2.2. Operating Ratio

Measures how efficient Fortress Biotech Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 3.81 means that the operating costs are $3.81 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Fortress Biotech Inc:

  • The MRQ is 3.806. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.722. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.806TTM2.722+1.084
TTM2.722YOY4.431-1.709
TTM2.7225Y3.461-0.738
5Y3.46110Y44.172-40.712
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8063.004+0.802
TTM2.7223.332-0.610
YOY4.4313.502+0.929
5Y3.4615.271-1.810
10Y44.1726.915+37.257
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Fortress Biotech Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Fortress Biotech Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.33 means the company has $1.33 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Fortress Biotech Inc:

  • The MRQ is 1.329. The company is just able to pay all its short-term debts.
  • The TTM is 1.176. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.329TTM1.176+0.153
TTM1.176YOY2.161-0.985
TTM1.1765Y3.166-1.990
5Y3.16610Y5.159-1.993
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3293.767-2.438
TTM1.1764.000-2.824
YOY2.1614.905-2.744
5Y3.1665.883-2.717
10Y5.1596.286-1.127
1.3.2. Quick Ratio

Measures if Fortress Biotech Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Fortress Biotech Inc to the Biotechnology industry mean.
  • A Quick Ratio of 1.09 means the company can pay off $1.09 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Fortress Biotech Inc:

  • The MRQ is 1.094. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 0.949. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ1.094TTM0.949+0.146
TTM0.949YOY1.973-1.024
TTM0.9495Y3.047-2.099
5Y3.04710Y5.543-2.495
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0943.054-1.960
TTM0.9493.506-2.557
YOY1.9734.756-2.783
5Y3.0475.757-2.710
10Y5.5436.338-0.795
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Fortress Biotech Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Fortress Biotech Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Fortress Biotech Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.02 means that Fortress Biotech Inc assets are financed with 102.4% credit (debt) and the remaining percentage (100% - 102.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Fortress Biotech Inc:

  • The MRQ is 1.024. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.048. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.024TTM1.048-0.024
TTM1.048YOY0.759+0.289
TTM1.0485Y0.672+0.376
5Y0.67210Y0.559+0.113
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0240.330+0.694
TTM1.0480.342+0.706
YOY0.7590.287+0.472
5Y0.6720.368+0.304
10Y0.5590.382+0.177
1.4.2. Debt to Equity Ratio

Measures if Fortress Biotech Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Fortress Biotech Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 732.2% means that company has $7.32 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Fortress Biotech Inc:

  • The MRQ is 7.322. The company is unable to pay all its debts with equity. -1
  • The TTM is 8.783. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ7.322TTM8.783-1.461
TTM8.783YOY4.677+4.106
TTM8.7835Y4.385+4.397
5Y4.38510Y4.727-0.342
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.3220.365+6.957
TTM8.7830.415+8.368
YOY4.6770.370+4.307
5Y4.3850.443+3.942
10Y4.7270.476+4.251
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Fortress Biotech Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Fortress Biotech Inc generates.

  • Above 15 is considered overpriced but always compare Fortress Biotech Inc to the Biotechnology industry mean.
  • A PE ratio of -0.56 means the investor is paying $-0.56 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Fortress Biotech Inc:

  • The EOD is -0.494. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.562. Based on the earnings, the company is expensive. -2
  • The TTM is -0.641. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.494MRQ-0.562+0.067
MRQ-0.562TTM-0.641+0.080
TTM-0.641YOY-0.098-0.544
TTM-0.6415Y-0.231-0.410
5Y-0.23110Y-0.141-0.090
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.494-2.341+1.847
MRQ-0.562-2.997+2.435
TTM-0.641-2.882+2.241
YOY-0.098-3.553+3.455
5Y-0.231-6.262+6.031
10Y-0.141-6.288+6.147
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Fortress Biotech Inc:

  • The EOD is -0.345. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.392. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.246. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.345MRQ-0.392+0.047
MRQ-0.392TTM-0.246-0.146
TTM-0.246YOY-0.046-0.200
TTM-0.2465Y-0.088-0.158
5Y-0.08810Y-0.113+0.025
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.345-2.932+2.587
MRQ-0.392-3.739+3.347
TTM-0.246-3.776+3.530
YOY-0.046-4.917+4.871
5Y-0.088-7.942+7.854
10Y-0.113-8.503+8.390
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Fortress Biotech Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -10.12 means the investor is paying $-10.12 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Fortress Biotech Inc:

  • The EOD is -8.903. Based on the equity, the company is expensive. -2
  • The MRQ is -10.117. Based on the equity, the company is expensive. -2
  • The TTM is 6.633. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD-8.903MRQ-10.117+1.214
MRQ-10.117TTM6.633-16.751
TTM6.633YOY0.279+6.354
TTM6.6335Y1.404+5.229
5Y1.40410Y0.740+0.664
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-8.9031.843-10.746
MRQ-10.1172.249-12.366
TTM6.6332.301+4.332
YOY0.2792.412-2.133
5Y1.4043.782-2.378
10Y0.7404.212-3.472
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Fortress Biotech Inc.

3.1. Institutions holding Fortress Biotech Inc

Institutions are holding 15.256% of the shares of Fortress Biotech Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31CVI Holdings LLC4.16044.75787645497645490
2023-12-31Nantahala Capital Management, LLC4.05470.06717451247451240
2023-12-31Rosalind Advisors, Inc.3.30741.50676077976077970
2023-12-31Armistice Capital, LLC3.24320.02455960005960000
2023-12-31Altium Capital Management, LP2.20450.82784051224051220
2023-12-31Vanguard Group Inc1.925803538933538930
2023-12-31Hudson Bay Capital Management LP1.78070.00623272353272350
2023-12-31Shikiar Asset Management Inc0.99660.1703183136106777139.8355
2023-12-31Acadian Asset Management LLC0.70840.00151301881301880
2023-12-31CI Private Wealth LLC0.58580.00061076581076580
2023-12-31Wealth Enhancement Advisory Services, LLC0.5160.000894816948160
2023-12-31National Asset Management Inc0.46780.00785975859750
2023-12-31BlackRock Inc0.4078074939749390
2023-12-31Envestnet Asset Management Inc0.33940.000162362623620
2023-12-31Geode Capital Management, LLC0.3085056699566990
2023-12-31Commonwealth Equity Services Inc0.28870.000353055530550
2023-12-31Advisor Group Holdings, Inc.0.21450.000239415394150
2023-12-31RSM US WEALTH MANAGEMENT LLC0.19730.00336250362500
2023-12-31JANE STREET GROUP, LLC0.1532028159281590
2023-12-31Renaissance Technologies Corp0.14080.000125867258670
Total 26.00157.3744778239+4701880+98.4%

3.2. Funds holding Fortress Biotech Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-04-30Vanguard Total Stock Mkt Idx Inv2.00540388544255687.044
2023-09-30BlackRock Extended Mkt Composite0.05420.000315751500
2024-04-30Vanguard Institutional Extnd Mkt Idx Tr0.78690.00031524743814633.3654
2024-04-30Fidelity Extended Market Index0.42130.000481619-740-0.8985
2024-04-30Fidelity Total Market Index0.121702357615688198.8844
2024-03-31NT Ext Equity Mkt Idx Fd - L0.11790.00072285217911362.4975
2024-03-31Northern Trust Extended Eq Market Idx0.11790.00072285217911362.4975
2024-03-31NT Ext Equity Mkt Idx Fd - NL0.11760.00072278318280405.9516
2024-03-31Fidelity VIP Disciplined Small Cap Init0.10650.01022062900
2024-03-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.09450.00071830814691406.1653
2024-03-31BlackRock Extended Equity Market K0.04730.0001916530.0327
2024-04-30Fidelity Series Total Market Index0.04440861000
2024-04-30Fidelity Nasdaq Composite Index0.04190.0001811500
2024-04-30Delaware Healthcare I0.03440.0015666600
2024-04-30Spartan Total Market Index Pool E0.02460477200
2024-03-31Perkins Discovery0.02390.1216463300
2024-05-31Fidelity Enhanced Small Cap ETF0.02080.0013403200
2023-12-31SSgA U.S. Extended Market Index Class I0.01410.0003273400
2024-05-31State St US Extended Mkt Indx NL Cl C0.01410.0003273400
2024-04-30Spartan Extended Market Index Pool E0.01170.0001226574048.5246
Total 4.22110.1393964878+148198+15.4%

3.3. Insider Transactions

Insiders are holding 25.407% of the shares of Fortress Biotech Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-05-20Dov KleinSELL100001.89
2024-05-16Lindsay A Md RosenwaldBUY100001.76
2024-01-05Lindsay A Md RosenwaldBUY500002.38
2023-11-14Lindsay A Md RosenwaldBUY15675151.7
2023-11-14Michael S WeissBUY1470581.7
2023-09-26Lindsay A Md RosenwaldBUY66664.2
2023-08-17Lindsay A Md RosenwaldBUY666176.25
3rd party ad coffee SUPPORTERis ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Fortress Biotech Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.277-0.298+7%-2.181+686%-0.137-51%-0.100-64%
Book Value Per Share---0.198-0.396+100%4.003-105%5.559-104%4.827-104%
Current Ratio--1.3291.176+13%2.161-39%3.166-58%5.159-74%
Debt To Asset Ratio--1.0241.048-2%0.759+35%0.672+52%0.559+83%
Debt To Equity Ratio--7.3228.783-17%4.677+57%4.385+67%4.727+55%
Dividend Per Share--0.1100.1100%0.1100%0.092+20%0.050+120%
Eps---0.890-0.739-17%-0.961+8%-0.762-14%-0.794-11%
Free Cash Flow Per Share---1.275-1.399+10%-2.228+75%-1.606+26%-1.209-5%
Free Cash Flow To Equity Per Share--0.124-0.917+839%-1.631+1414%-0.220+277%-0.061+149%
Gross Profit Margin--1.0001.0000%1.0000%1.279-22%1.444-31%
Intrinsic Value_10Y_max---50.850--------
Intrinsic Value_10Y_min---69.950--------
Intrinsic Value_1Y_max---4.881--------
Intrinsic Value_1Y_min---7.461--------
Intrinsic Value_3Y_max---14.829--------
Intrinsic Value_3Y_min---22.160--------
Intrinsic Value_5Y_max---24.974--------
Intrinsic Value_5Y_min---36.462--------
Market Cap35052336.000-14%39832200.00029127296.250+37%8215391.250+385%10599348.420+276%8234809.448+384%
Net Profit Margin---1.361-0.849-38%-1.808+33%-1.161-15%-21.563+1485%
Operating Margin---2.938-1.753-40%-3.431+17%-2.482-16%-22.602+669%
Operating Ratio--3.8062.722+40%4.431-14%3.461+10%44.172-91%
Pb Ratio-8.903+12%-10.1176.633-253%0.279-3728%1.404-820%0.740-1467%
Pe Ratio-0.494+12%-0.562-0.641+14%-0.098-83%-0.231-59%-0.141-75%
Price Per Share1.760-14%2.0001.463+37%0.413+385%0.532+276%0.413+384%
Price To Free Cash Flow Ratio-0.345+12%-0.392-0.246-37%-0.046-88%-0.088-78%-0.113-71%
Price To Total Gains Ratio-10.495+12%-11.926-1.887-84%-0.232-98%-0.440-96%-1.141-90%
Quick Ratio--1.0940.949+15%1.973-45%3.047-64%5.543-80%
Return On Assets---0.108-0.083-23%-0.095-12%-0.063-42%-0.076-29%
Return On Equity---0.770-0.706-8%-0.616-20%-0.414-46%-0.675-12%
Total Gains Per Share---0.168-0.188+12%-2.071+1135%-0.046-73%-0.050-70%
Usd Book Value---3937000.000-7884000.000+100%79721250.000-105%110721850.000-104%96142725.000-104%
Usd Book Value Change Per Share---0.277-0.298+7%-2.181+686%-0.137-51%-0.100-64%
Usd Book Value Per Share---0.198-0.396+100%4.003-105%5.559-104%4.827-104%
Usd Dividend Per Share--0.1100.1100%0.1100%0.092+20%0.050+120%
Usd Eps---0.890-0.739-17%-0.961+8%-0.762-14%-0.794-11%
Usd Free Cash Flow---25387000.000-27872500.000+10%-44369750.000+75%-31981450.000+26%-24081750.000-5%
Usd Free Cash Flow Per Share---1.275-1.399+10%-2.228+75%-1.606+26%-1.209-5%
Usd Free Cash Flow To Equity Per Share--0.124-0.917+839%-1.631+1414%-0.220+277%-0.061+149%
Usd Market Cap35052336.000-14%39832200.00029127296.250+37%8215391.250+385%10599348.420+276%8234809.448+384%
Usd Price Per Share1.760-14%2.0001.463+37%0.413+385%0.532+276%0.413+384%
Usd Profit---17731000.000-14207750.000-20%-28474750.000+61%-16653800.000-6%-14981150.000-16%
Usd Revenue--13030000.00021278500.000-39%16061750.000-19%15891400.000-18%13915350.000-6%
Usd Total Gains Per Share---0.168-0.188+12%-2.071+1135%-0.046-73%-0.050-70%
 EOD+2 -6MRQTTM+21 -14YOY+21 -145Y+13 -2310Y+13 -23

4.2. Fundamental Score

Let's check the fundamental score of Fortress Biotech Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.494
Price to Book Ratio (EOD)Between0-1-8.903
Net Profit Margin (MRQ)Greater than0-1.361
Operating Margin (MRQ)Greater than0-2.938
Quick Ratio (MRQ)Greater than11.094
Current Ratio (MRQ)Greater than11.329
Debt to Asset Ratio (MRQ)Less than11.024
Debt to Equity Ratio (MRQ)Less than17.322
Return on Equity (MRQ)Greater than0.15-0.770
Return on Assets (MRQ)Greater than0.05-0.108
Total2/10 (20.0%)

4.3. Technical Score

Let's check the technical score of Fortress Biotech Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.324
Ma 20Greater thanMa 501.798
Ma 50Greater thanMa 1001.795
Ma 100Greater thanMa 2001.860
OpenGreater thanClose1.690
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets164,645
Total Liabilities168,582
Total Stockholder Equity23,025
 As reported
Total Liabilities 168,582
Total Stockholder Equity+ 23,025
Total Assets = 164,645

Assets

Total Assets164,645
Total Current Assets116,548
Long-term Assets48,097
Total Current Assets
Cash And Cash Equivalents 85,837
Net Receivables 10,123
Inventory 10,580
Other Current Assets 10,008
Total Current Assets  (as reported)116,548
Total Current Assets  (calculated)116,548
+/-0
Long-term Assets
Property Plant Equipment 22,590
Intangible Assets 19,473
Long-term Assets Other 3,971
Long-term Assets  (as reported)48,097
Long-term Assets  (calculated)46,034
+/- 2,063

Liabilities & Shareholders' Equity

Total Current Liabilities87,696
Long-term Liabilities80,886
Total Stockholder Equity23,025
Total Current Liabilities
Short-term Debt 9,622
Short Long Term Debt 3,000
Accounts payable 41,803
Other Current Liabilities 35,428
Total Current Liabilities  (as reported)87,696
Total Current Liabilities  (calculated)89,853
+/- 2,157
Long-term Liabilities
Long term Debt 61,420
Capital Lease Obligations 20,220
Long-term Liabilities Other 1,847
Long-term Liabilities  (as reported)80,886
Long-term Liabilities  (calculated)83,487
+/- 2,601
Total Stockholder Equity
Common Stock19
Retained Earnings -710,287
Other Stockholders Equity 733,293
Total Stockholder Equity (as reported)23,025
Total Stockholder Equity (calculated)23,025
+/-0
Other
Capital Stock22
Cash and Short Term Investments 85,837
Common Stock Shares Outstanding 17,152
Current Deferred Revenue843
Liabilities and Stockholders Equity 164,645
Net Debt 2,824
Net Invested Capital 87,442
Net Working Capital 28,852
Property Plant and Equipment Gross 31,859
Short Long Term Debt Total 88,661



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-03-312009-12-31
> Total Assets 
1,687
0
0
14,939
0
0
26,806
23,375
18,043
38,493
48,085
40,992
45,456
68,778
107,107
100,582
94,902
90,870
88,007
89,331
90,451
83,699
86,864
118,610
104,913
98,062
145,421
170,731
211,911
249,846
245,091
245,950
265,075
236,866
224,919
140,993
200,538
227,264
221,588
226,422
228,759
268,573
295,879
328,834
391,043
418,158
407,833
396,503
407,930
363,955
323,561
294,301
263,551
180,719
150,549
167,526
164,645
164,645167,526150,549180,719263,551294,301323,561363,955407,930396,503407,833418,158391,043328,834295,879268,573228,759226,422221,588227,264200,538140,993224,919236,866265,075245,950245,091249,846211,911170,731145,42198,062104,913118,61086,86483,69990,45189,33188,00790,87094,902100,582107,10768,77845,45640,99248,08538,49318,04323,37526,8060014,939001,687
   > Total Current Assets 
0
0
0
0
0
0
26,806
23,375
18,043
38,493
47,995
40,592
45,062
68,129
106,546
100,031
80,504
76,479
72,072
70,463
69,613
62,034
66,610
99,779
84,336
76,552
98,583
109,634
151,807
190,180
184,087
183,181
200,157
171,524
159,518
111,207
136,549
163,511
166,312
156,252
158,801
199,799
237,737
261,571
317,993
320,345
301,187
346,462
341,186
298,991
257,994
230,432
202,381
127,611
97,826
117,022
116,548
116,548117,02297,826127,611202,381230,432257,994298,991341,186346,462301,187320,345317,993261,571237,737199,799158,801156,252166,312163,511136,549111,207159,518171,524200,157183,181184,087190,180151,807109,63498,58376,55284,33699,77966,61062,03469,61370,46372,07276,47980,504100,031106,54668,12945,06240,59247,99538,49318,04323,37526,806000000
       Cash And Cash Equivalents 
1,510
0
0
14,862
0
0
26,708
23,160
17,735
38,207
47,478
40,199
44,052
67,886
106,267
99,521
79,982
75,798
71,592
49,759
48,928
41,037
25,563
98,182
81,415
71,336
82,537
88,294
134,037
144,344
110,536
113,915
124,020
98,591
95,867
65,508
116,444
149,407
134,945
136,858
135,943
183,278
218,389
233,351
289,897
274,992
252,721
305,744
287,511
248,771
208,351
178,266
152,483
78,022
72,307
80,927
85,837
85,83780,92772,30778,022152,483178,266208,351248,771287,511305,744252,721274,992289,897233,351218,389183,278135,943136,858134,945149,407116,44465,50895,86798,591124,020113,915110,536144,344134,03788,29482,53771,33681,41598,18225,56341,03748,92849,75971,59275,79879,98299,521106,26767,88644,05240,19947,47838,20717,73523,16026,7080014,862001,510
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
295
52
20,002
20,005
20,000
39,951
0
0
0
3,208
3,387
2,236
24,484
46,723
39,028
42,321
39,648
29,549
17,604
5,044
5,000
5,000
0
0
0
0
17,566
0
48,484
0
0
0
0
0
0
0
0
0
0
0
0000000000048,484017,56600005,0005,0005,04417,60429,54939,64842,32139,02846,72324,4842,2363,3873,20800039,95120,00020,00520,0025229500000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
349
344
0
0
0
0
69
0
156
0
0
0
156
1,314
3,537
8,159
8,689
6,788
9,151
15,771
17,387
19,256
19,106
19,339
7,593
10,151
4,954
6,380
14,404
17,563
12,109
16,592
20,093
20,288
27,035
32,685
23,790
31,814
29,047
28,686
28,346
28,252
17,010
8,154
15,389
10,123
10,12315,3898,15417,01028,25228,34628,68629,04731,81423,79032,68527,03520,28820,09316,59212,10917,56314,4046,3804,95410,1517,59319,33919,10619,25617,38715,7719,1516,7888,6898,1593,5371,314156000156069000034434900000000000
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
123
203
204
299
318
171
222
299
674
678
629
732
941
857
769
1,209
1,052
1,404
2,291
14,315
11,614
9,862
16,137
16,053
15,230
14,159
13,278
12,166
11,024
10,206
10,580
10,58010,20611,02412,16613,27814,15915,23016,05316,1379,86211,61414,3152,2911,4041,0521,2097698579417326296786742992221713182992042031231000000000000000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
90
400
394
649
561
551
14,398
14,391
15,935
18,868
20,838
21,665
20,254
18,831
20,577
21,510
46,838
61,097
60,104
59,666
61,004
62,769
64,918
65,342
65,401
29,786
63,989
63,753
55,276
70,170
69,958
68,774
58,142
67,263
73,050
97,813
106,646
50,041
66,744
64,964
65,567
63,869
61,170
53,108
52,723
50,504
48,097
48,09750,50452,72353,10861,17063,86965,56764,96466,74450,041106,64697,81373,05067,26358,14268,77469,95870,17055,27663,75363,98929,78665,40165,34264,91862,76961,00459,66660,10461,09746,83821,51020,57718,83120,25421,66520,83818,86815,93514,39114,398551561649394400900000000000
       Property Plant Equipment 
15
0
0
22
0
0
0
0
0
0
0
51
50
535
452
447
69
63
58
52
46
90
129
309
2,598
4,535
6,957
7,376
7,386
7,329
8,221
9,513
12,278
14,163
14,642
12,019
34,451
34,278
34,028
33,913
33,861
33,035
32,379
32,410
32,363
32,857
33,390
34,071
32,995
32,137
33,529
33,011
31,661
25,181
24,361
23,495
22,590
22,59023,49524,36125,18131,66133,01133,52932,13732,99534,07133,39032,85732,36332,41032,37933,03533,86133,91334,02834,27834,45112,01914,64214,16312,2789,5138,2217,3297,3867,3766,9574,5352,59830912990465258636944745253550510000000220015
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,739
18,645
18,645
18,645
18,645
18,645
18,645
18,645
18,645
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000018,64518,64518,64518,64518,64518,64518,64518,64521,73900000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
250
0
250
0
0
0
0
0
0
0
0
0
0
0
0
0
1,272
565
0
0
11,056
11,193
11,193
11,148
11,148
11,148
11,723
17,566
23,479
48,484
56,860
0
0
0
0
0
0
0
0
0
0
000000000056,86048,48423,47917,56611,72311,14811,14811,14811,19311,19311,056005651,272000000000000025002500000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,250
1,250
1,250
1,250
1,450
1,579
1,550
17,408
17,077
16,533
15,983
15,223
14,400
13,614
13,935
1,417
1,183
971
7,731
7,377
7,022
6,667
11,039
14,629
14,442
13,701
13,043
12,552
30,457
29,440
28,424
27,197
26,128
21,916
21,102
20,287
19,473
19,47320,28721,10221,91626,12827,19728,42429,44030,45712,55213,04313,70114,44214,62911,0396,6677,0227,3777,7319711,1831,41713,93513,61414,40015,22315,98316,53317,07717,4081,5501,5791,4501,2501,2501,2501,25000000000000000000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
90
349
344
114
109
104
14,079
14,078
15,627
14,656
15,597
14,758
14,780
14,787
14,962
14,630
15,907
16,254
16,250
16,256
17,232
17,998
18,323
18,355
18,179
16,350
17,299
17,311
2,324
17,732
17,927
17,924
3,001
2,658
2,766
2,771
3,353
3,418
3,292
3,387
3,614
3,661
3,381
6,011
7,260
4,284
3,971
3,9714,2847,2606,0113,3813,6613,6143,3873,2923,4183,3532,7712,7662,6583,00117,92417,92717,7322,32417,31117,29916,35018,17918,35518,32317,99817,23216,25616,25016,25415,90714,63014,96214,78714,78014,75815,59714,65615,62714,07814,079104109114344349900000000000
> Total Liabilities 
11,777
0
0
1,559
0
0
71,448
4,243
4,593
4,676
18,957
18,959
18,728
20,220
19,593
19,304
19,410
18,502
18,747
18,808
30,264
28,491
31,943
34,337
34,004
39,848
70,580
87,763
85,594
99,230
123,826
125,448
157,529
140,601
140,282
121,250
149,829
137,444
146,588
153,890
153,474
151,715
119,734
131,835
146,818
169,857
195,365
170,626
214,352
216,253
222,209
244,276
243,745
196,662
163,792
165,939
168,582
168,582165,939163,792196,662243,745244,276222,209216,253214,352170,626195,365169,857146,818131,835119,734151,715153,474153,890146,588137,444149,829121,250140,282140,601157,529125,448123,82699,23085,59487,76370,58039,84834,00434,33731,94328,49130,26418,80818,74718,50219,41019,30419,59320,22018,72818,95918,9574,6764,5934,24371,448001,5590011,777
   > Total Current Liabilities 
11,207
0
0
1,559
0
0
3,693
3,493
3,843
3,926
4,465
5,132
6,168
8,953
9,644
11,210
4,335
3,437
3,557
4,077
5,928
4,995
8,450
10,579
10,837
14,337
38,593
56,565
52,800
53,468
68,428
67,428
79,326
62,158
70,775
55,614
48,957
36,398
46,853
45,616
51,732
56,969
37,281
47,959
53,820
70,602
103,213
101,042
103,140
104,921
106,303
127,715
129,473
128,583
97,351
84,908
87,696
87,69684,90897,351128,583129,473127,715106,303104,921103,140101,042103,21370,60253,82047,95937,28156,96951,73245,61646,85336,39848,95755,61470,77562,15879,32667,42868,42853,46852,80056,56538,59314,33710,83710,5798,4504,9955,9284,0773,5573,4374,33511,2109,6448,9536,1685,1324,4653,9263,8433,4933,693001,5590011,207
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
1,799
3,190
4,611
6,062
6,203
165
165
165
165
165
165
165
146
146
146
25,324
2,031
5,252
6,218
12,956
13,228
12,651
10,573
19,711
19,078
10,758
11,022
17,213
9,004
16,316
23,575
1,697
7,149
7,303
5,896
16,930
7,426
9,492
9,579
11,393
12,630
10,121
14,604
5,413
9,454
9,622
9,6229,4545,41314,60410,12112,63011,3939,5799,4927,42616,9305,8967,3037,1491,69723,57516,3169,00417,21311,02210,75819,07819,71110,57312,65113,22812,9566,2185,2522,03125,3241461461461651651651651651651656,2036,0624,6113,1901,79900000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
114
0
0
0
114
0
302
14,980
14,452
16,467
18,552
25,161
23,380
12,651
10,573
19,711
19,078
9,277
9,396
15,472
7,220
14,522
21,823
0
5,300
5,463
3,861
14,883
5,322
7,363
7,487
9,122
10,183
7,606
12,275
3,000
3,000
3,000
3,0003,0003,00012,2757,60610,1839,1227,4877,3635,32214,8833,8615,4635,300021,82314,5227,22015,4729,3969,27719,07819,71110,57312,65123,38025,16118,55216,46714,45214,98030201140001140000000000000000000
       Accounts payable 
628
0
0
522
0
0
950
575
1,001
753
840
1,029
676
1,429
1,114
468
872
331
333
366
664
583
1,287
1,868
2,348
5,126
21,831
24,295
24,864
24,995
31,978
36,349
44,849
38,199
37,498
34,216
37,089
24,260
28,512
35,451
34,213
31,836
32,561
40,674
11,370
14,271
42,781
47,429
44,532
53,939
55,765
57,244
65,868
48,587
44,731
34,810
41,803
41,80334,81044,73148,58765,86857,24455,76553,93944,53247,42942,78114,27111,37040,67432,56131,83634,21335,45128,51224,26037,08934,21637,49838,19944,84936,34931,97824,99524,86424,29521,8315,1262,3481,8681,2875836643663333318724681,1141,4296761,0298407531,0015759500052200628
       Other Current Liabilities 
1,610
0
0
1,037
0
0
2,743
2,918
2,842
3,173
3,625
2,304
2,302
2,913
2,412
4,349
3,298
2,941
3,059
3,546
5,099
4,247
6,998
114
203
302
16,762
17,139
10,743
8,575
22,814
6,016
21,136
12,736
13,411
991
1,110
1,116
1,128
27
69
413
3,000
38,396
27,947
45,635
40,148
43,576
47,082
39,946
38,052
57,113
52,937
14,817
10,448
39,801
35,428
35,42839,80110,44814,81752,93757,11338,05239,94647,08243,57640,14845,63527,94738,3963,00041369271,1281,1161,11099113,41112,73621,1366,01622,8148,57510,74317,13916,7623022031146,9984,2475,0993,5463,0592,9413,2984,3492,4122,9132,3022,3043,6253,1732,8422,9182,743001,037001,610
   > Long-term Liabilities 
0
0
0
0
0
0
67,755
750
750
750
14,492
13,827
12,560
11,267
9,949
8,094
15,075
15,065
15,190
14,731
24,336
23,496
23,493
23,758
23,167
25,511
31,987
31,198
32,794
45,762
55,398
58,020
78,203
78,443
69,507
65,636
100,872
101,046
99,735
108,274
101,742
94,746
82,453
83,876
92,998
99,255
92,152
69,584
111,212
111,332
115,906
116,561
114,272
68,079
66,441
81,031
80,886
80,88681,03166,44168,079114,272116,561115,906111,332111,21269,58492,15299,25592,99883,87682,45394,746101,742108,27499,735101,046100,87265,63669,50778,44378,20358,02055,39845,76232,79431,19831,98725,51123,16723,75823,49323,49624,33614,73115,19015,06515,0758,0949,94911,26712,56013,82714,49275075075067,755000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
9,760
8,408
7,017
14,009
14,009
14,009
14,009
24,009
23,232
23,291
0
0
0
0
0
0
0
0
0
0
0
64,546
60,425
73,607
74,307
73,384
82,426
76,006
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000076,00682,42673,38474,30773,60760,42564,5460000000000023,29123,23224,00914,00914,00914,00914,0097,0178,4089,7600000000000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000003400000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
398
1,441
1,474
1,507
1,541
1,077
1,066
1,056
1,181
722
327
264
202
584
2,416
3,706
4,583
5,014
5,020
5,026
4,736
4,739
4,759
4,987
4,961
5,211
2,276
2,229
2,183
2,136
2,089
2,043
1,996
1,949
2,265
6,143
6,444
2,033
1,986
1,940
1,893
0
1,800
1,754
0
0
0
0001,7541,80001,8931,9401,9862,0336,4446,1432,2651,9491,9962,0432,0892,1362,1832,2292,2765,2114,9614,9874,7594,7394,7365,0265,0205,0144,5833,7062,4165842022643277221,1811,0561,0661,0771,5411,5071,4741,4413980000000000
> Total Stockholder Equity
0
0
0
13,380
0
0
-44,642
19,132
13,450
33,817
29,128
22,033
26,728
48,558
87,514
81,278
75,492
72,368
69,260
70,523
60,153
55,881
53,611
56,846
44,565
35,337
36,626
38,495
47,746
72,271
36,944
52,573
41,651
43,933
37,773
1,852
20,817
31,874
25,795
26,215
37,228
60,477
97,111
100,338
105,902
108,281
92,658
108,674
97,859
77,223
61,671
41,721
37,796
18,509
16,674
22,544
23,025
23,02522,54416,67418,50937,79641,72161,67177,22397,859108,67492,658108,281105,902100,33897,11160,47737,22826,21525,79531,87420,8171,85237,77343,93341,65152,57336,94472,27147,74638,49536,62635,33744,56556,84653,61155,88160,15370,52369,26072,36875,49281,27887,51448,55826,72822,03329,12833,81713,45019,132-44,6420013,380000
   Retained Earnings -710,287-694,870-685,591-680,546-655,770-634,233-607,090-584,579-563,223-547,463-515,898-495,117-491,582-482,760-477,465-461,918-448,604-436,234-420,742-407,980-394,882-396,274-371,394-354,756-333,145-312,127-301,714-274,598-257,233-245,251-227,820-214,839-202,361-190,156-178,120-159,959-153,784-141,728-138,015-133,423-128,712-121,342-111,544-103,712-93,042-84,184-75,519-69,585-63,130-56,574-49,855000000
   Accumulated Other Comprehensive Income -3-150-300000-300-7,369-6,766-6,162-5,589-5,013-4,486-3,978-3,502-3,045-2,564-3,025-2,477-2,011-1,646-1,300-1,024-755-481-296-142-60-68-59-53-48-42-37-31-25-20-14-10-6-30000-29,277000000
   Capital Surplus 
0
0
0
0
0
0
5,206
0
0
0
0
106,193
119,744
152,240
199,023
202,580
204,160
205,747
207,231
212,205
213,890
215,793
231,684
246,955
246,877
250,127
264,397
283,697
304,929
346,630
338,254
364,148
374,254
397,858
408,615
397,408
414,870
439,295
445,966
461,874
485,160
521,493
574,461
0
597,384
603,035
608,089
656,033
660,973
661,691
668,650
0
693,433
698,897
0
0
0
000698,897693,4330668,650661,691660,973656,033608,089603,035597,3840574,461521,493485,160461,874445,966439,295414,870397,408408,615397,858374,254364,148338,254346,630304,929283,697264,397250,127246,877246,955231,684215,793213,890212,205207,231205,747204,160202,580199,023152,240119,744106,19300005,206000000
   Treasury Stock0000000000000000-700000000000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue84,513
Cost of Revenue-28,890
Gross Profit55,62355,623
 
Operating Income (+$)
Gross Profit55,623
Operating Expense-194,865
Operating Income-139,242-139,242
 
Operating Expense (+$)
Research Development106,071
Selling General Administrative99,711
Selling And Marketing Expenses0
Operating Expense194,865205,782
 
Net Interest Income (+$)
Interest Income2,983
Interest Expense-11,915
Other Finance Cost-6,086
Net Interest Income-15,018
 
Pretax Income (+$)
Operating Income-139,242
Net Interest Income-15,018
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-153,633-124,851
EBIT - interestExpense = -151,157
-60,116
-48,722
Interest Expense11,915
Earnings Before Interest and Taxes (EBIT)-139,242-141,718
Earnings Before Interest and Taxes (EBITDA)-131,167
 
After tax Income (+$)
Income Before Tax-153,633
Tax Provision-591
Net Income From Continuing Ops-182,615-154,224
Net Income-60,637
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses223,755
Total Other Income/Expenses Net-14,39115,018
 

Technical Analysis of Fortress Biotech Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Fortress Biotech Inc. The general trend of Fortress Biotech Inc is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Fortress Biotech Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Fortress Biotech Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.76 < 1.76 < 1.76.

The bearish price targets are: 1.66 > 1.66 > 1.66.

Tweet this
Fortress Biotech Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Fortress Biotech Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Fortress Biotech Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Fortress Biotech Inc. The current macd is -0.03825443.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Fortress Biotech Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Fortress Biotech Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Fortress Biotech Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Fortress Biotech Inc Daily Moving Average Convergence/Divergence (MACD) ChartFortress Biotech Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Fortress Biotech Inc. The current adx is 14.21.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Fortress Biotech Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Fortress Biotech Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Fortress Biotech Inc. The current sar is 1.89911564.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Fortress Biotech Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Fortress Biotech Inc. The current rsi is 48.32. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Fortress Biotech Inc Daily Relative Strength Index (RSI) ChartFortress Biotech Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Fortress Biotech Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Fortress Biotech Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Fortress Biotech Inc Daily Stochastic Oscillator ChartFortress Biotech Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Fortress Biotech Inc. The current cci is -32.59896113.

Fortress Biotech Inc Daily Commodity Channel Index (CCI) ChartFortress Biotech Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Fortress Biotech Inc. The current cmo is 0.61685356.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Fortress Biotech Inc Daily Chande Momentum Oscillator (CMO) ChartFortress Biotech Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Fortress Biotech Inc. The current willr is -64.44444444.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Fortress Biotech Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Fortress Biotech Inc Daily Williams %R ChartFortress Biotech Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Fortress Biotech Inc.

Fortress Biotech Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Fortress Biotech Inc. The current atr is 0.11283704.

Fortress Biotech Inc Daily Average True Range (ATR) ChartFortress Biotech Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Fortress Biotech Inc. The current obv is 7,109,880.

Fortress Biotech Inc Daily On-Balance Volume (OBV) ChartFortress Biotech Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Fortress Biotech Inc. The current mfi is 37.82.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Fortress Biotech Inc Daily Money Flow Index (MFI) ChartFortress Biotech Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Fortress Biotech Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-02-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-05-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-06-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-06-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Fortress Biotech Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Fortress Biotech Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.324
Ma 20Greater thanMa 501.798
Ma 50Greater thanMa 1001.795
Ma 100Greater thanMa 2001.860
OpenGreater thanClose1.690
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Fortress Biotech Inc with someone you think should read this too:
  • Are you bullish or bearish on Fortress Biotech Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Fortress Biotech Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Fortress Biotech Inc

I send you an email if I find something interesting about Fortress Biotech Inc.


Stay informed about Fortress Biotech Inc.

Receive notifications about Fortress Biotech Inc in your mailbox!